Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTLWS2O)

DTT Name	Calcitonin receptor (CALCR) DTT Info
Gene Name	CALCR

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Approved Drug(s)

Discontinued Drug(s)

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

2 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Calcitonin Human	DM0N9WA	Paget's disease	FB85	Approved	[1]
Salmon Calcitonin	DMEWUPF	Bone Paget disease		Approved	[2]
------------------------------------------------------------------------------------

2 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
DACRA 089	DM5TB76	Type 2 diabetes	5A11	Phase 1	[3]
LY 3541105	DMJ1X85	Obesity	5B81	Phase 1	[4]
------------------------------------------------------------------------------------

1 Discontinued Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
TJN-220	DM4YQDX	Hypertension	BA00-BA04	Terminated	[5]
------------------------------------------------------------------------------------

13 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
CGNLSTCBLGTYTQDFNKFHZYPQTAIGVGAP-amide	DMLA384	Discovery agent	N.A.	Investigative	[6]
CGNLSTCBLGTYTQDF[DKFHO]YPQTAIGVGAP-amide	DMQ3SAY	Discovery agent	N.A.	Investigative	[6]
CGNLSTCMLGTYTQDFc[DKFHK]FPQTAIGVGAP-amide	DMUGAYT	Discovery agent	N.A.	Investigative	[6]
CGNLSTCMLGTYTQDFc[DKFHO]FPQTAIGVGAP-amide	DM3FP47	Discovery agent	N.A.	Investigative	[6]
CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-amide	DMJ9Z31	Discovery agent	N.A.	Investigative	[6]
CGNLSTCMLGTYTQDFNKPHTFPQTAIGVGAP-amide	DME84PN	Discovery agent	N.A.	Investigative	[6]
CGNLSTCMLGTYTQDFNPFHTFPQTAIGVGAP-amide	DMV7TE4	Discovery agent	N.A.	Investigative	[6]
CGNLSTCMLGTYTQDFNPKHTFPQTAIGVGAP-amide	DMMO8A2	Discovery agent	N.A.	Investigative	[6]
CSNLSTCVLGKLSQELc[DKLHK]YPRTNTGSGTP-amide	DMYDTO8	Discovery agent	N.A.	Investigative	[6]
CSNLSTCVLGKLSQELc[DKLHO]YPRTNTGSGTP-amide	DMQXEHJ	Discovery agent	N.A.	Investigative	[6]
CSNLSTCVLGKLSQELc[DKLQK]YPRTNTGSGTP-amide	DMMZK89	Discovery agent	N.A.	Investigative	[6]
CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP-amide	DMTL2BA	Discovery agent	N.A.	Investigative	[6]
CSNLSTCVLGKLSQELNKLHBYPRTNTGSGTP-amide	DM61V5W	Discovery agent	N.A.	Investigative	[6]
------------------------------------------------------------------------------------


⏷ Show the Full List of 13 Investigative Drug(s)

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
2	Improved absorption of salmon calcitonin by ultraflexible liposomes through intranasal delivery. Peptides. 2009 Jul;30(7):1288-95.
3	A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference. Br J Pharmacol. 2017 Apr;174(7):591-602.
4	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight
5	Evaluation of the long-lasting antihypertensive action of 7-O-ethylfangchinoline. Jpn J Pharmacol. 1994 Sep;66(1):35-46.
6	Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept fo... J Med Chem. 2002 Feb 28;45(5):1108-21.